Press release
First-hand information, exhaustive and accurate, about our company
What makes León a European benchmark in biotechnology?
In recent years, the biotechnology sector has become one of the fundamental pillars of the economy of León, with its impact accounting for a large part of the total economy of the region. In addition, it should be noted that this biotechnology sector is the one that...
WACKER Purchases ADL Biopharma, Strengthening Its Biotechnology Business
To read the full article; WACKER Purchases ADL BioPharma in Spain, Strengthening Its Biotechnology Business - Wacker Chemie AG
ADL Biopharma further raises its quality standards
ADL Biopharma has just successfully implemented an Integrated Management System based on continuous improvement, which has significantly increased the factory's standards of quality and excellence. This Integrated Management System integrates the areas of Quality,...
ADL BIOPHARMA GROWS BY 40% IN SALES AND MORE THAN DOUBLES ITS ECONOMIC RESULT
ADL Biopharma, leader in precision fermentation biotechnology production, announced today its results for the year 2022. Despite the challenging market conditions, the company reported an impressive 40% growth in sales, taking turnover to €53m. The vitality of sales...
Presentation of the Innovation Valley of Castilla y León
Last Tuesday, the presentation of the Innovation Valley of Castilla y León took place in Burgos, where ADL Biopharma is of great importance due to its history, its capacity for innovation in food and personal care industries, and its industrial infrastructure. The...
ADL Biopharma attended the 3rd Fermentation-Enable Alternative Protein Summit
ADL Biopharma attended the 3rd Fermentation-Enable Alternative Protein, an event in California that brings together the most important companies in the fermentation biotechnology sector. The 3 days of this outstanding event have been an opportunity for ADL to...
Letter from the CEO
With the first month of 2023 already behind us, it is time for me to reach out and wish you and your families a very good year, abundant with happiness, success, and positive experiences. We at ADL Biopharma are excited about the opportunities and adventures this new...
Capital increase strengthens ADL’s position
ADL BioPharma increases capital by EUR 24 million, which is 100% subscribed by Kartesia as the sole shareholder, by converting an equivalent amount of all its old loans in the company. In this way, ADL significantly reduces its debt ratios and financial interest...
The Minister of Industry of the Autonomous Government of Castilla y León visits ADL BioPharma
ADL BioPharma's facilities have received the visit of Mr. Mariano Veganzones Díez, Minister of Industry, Trade and Employment of the Junta de Castilla y León, and Mr. Fernando Campo González, General Director of Industry. With the help of our president and CEO, Mr....
The Intelligent Control group of the Spanish Committee of Automatics makes a technical visit to ADL BioPharma’s factory in the context of its XVII Symposium
ADL BioPharma has received this Tuesday 28th in its factory in León a representation of the attendees of the XVII Symposium of Intelligent Control of the Spanish Committee of Automatics, with the aim of strengthening ties and making a technical visit to the factory....
ADL BioPharma participates in “Expo León i4.0” fair
In ADL BioPharma we continue to strengthen ties with the University of Leon and betting on local talent. On May 20, we were present at the "Expo León i4.0" fair, which brought together about thirty companies from the technological and industrial sector of the province...
Boosting technology transfer through an agreement with the University of Leon
The Rector of the University of Leon, Juan Francisco García Marín, together with the Business Relations Department Director, Nuria González Rabanal, visited ADL BioPharma facilities on Thursday, May 12, and signed the agreement between both institutions. This...
ADL BioPharma closes 2021 with a turnover increase of more than 60%
ADL BioPharma had a turnover of nearly 38 million euros, thus increasing its sales by almost 14.5 million euros compared to 2020, and was able to sign long-term customer contracts. ADL BioPharma closed 2021 with a turnover of 38 million euros, which is almost 14.5...
ADL BioPharma and the Halal Institute sign a pioneering collaboration agreement in the biotechnology sector
The Halal Institute, with offices in Cordoba, Lisbon and Mexico City, will offer certification services for all the processes and products produced at ADL BioPharma facilities, while the Leon-based company will promote the application of the Islamic Board’s Halal...
ADL BioPharma renews its corporate image and consolidates itself as a strategic partner in Europe to accelerate and optimize biotechnology projects
In this new stage they are committed to innovation, resource optimization and the product quality from economic and environmental sustainability. The biopharmaceutical Company ADL BioPharma, with more than 60 years of experience in the biopharmaceutical sector, renews...
The Fire Brigade Sergeant of León visits ADL BioPharma premises
This visit shows the good coordination between the León Fire Brigade and ADL, and proves the factory's commitment to safety in all its facilities. On Friday 3rd December 2021, ADL BioPharma Emergency Directors and Intervention Managers received a visit from Santos...
